Low high-density lipoprotein cholesterol and cardiovascular disease: risk reduction with statin therapy

American Heart Journal
Robert S Rosenson

Abstract

A low level of high-density lipoprotein cholesterol (HDL-C) is a major risk factor for cardiovascular disease; however, patients with low levels of HDL-C without raised low-density lipoprotein cholesterol (LDL-C) levels are not currently eligible for lipid-lowering therapy. Many individuals with low levels of HDL-C have a combination of cardiovascular risk factors that include high LDL particle concentrations. Lowering LDL particle concentration and its surrogate measure, LDL-C, is an important approach to reducing cardiovascular risk. Statins are the most effective agents for lowering levels of LDL and can significantly increase levels of HDL-C. Extending statin therapy to patients with low levels of HDL-C but with LDL-C levels below target may have benefits for cardiovascular disease reduction in these patients.

References

Jun 1, 1991·The American Journal of Cardiology·J J GenestE J Schaefer
Sep 28, 1995·The American Journal of Cardiology·W B Kannel
Nov 1, 1994·Arteriosclerosis and Thrombosis : a Journal of Vascular Biology·R M EpandG M Anantharamaiah
Oct 23, 1997·Thrombosis Research·C PirichH Sinzinger
Dec 5, 1998·The New England Journal of Medicine·UNKNOWN Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group
May 23, 2001·JAMA : the Journal of the American Medical Association·UNKNOWN Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults
Jun 5, 2002·Current Opinion in Lipidology·Philip J BarterKerry-Anne Rye
Nov 7, 2002·The American Journal of Cardiology·James D OtvosWilliam C Cromwell
Nov 30, 2002·Lancet·James ShepherdUNKNOWN PROSPER study group. PROspective Study of Pravastatin in the Elderly at Risk
May 31, 2003·Arteriosclerosis, Thrombosis, and Vascular Biology·Takao KimuraFumikazu Okajima
Jul 16, 2003·The American Journal of Cardiology·Peter H JonesUNKNOWN STELLAR Study Group
Aug 16, 2003·Arteriosclerosis, Thrombosis, and Vascular Biology·Anatol KontushM John Chapman
Sep 13, 2003·Arteriosclerosis, Thrombosis, and Vascular Biology·Laura CalabresiGuido Franceschini
Oct 16, 2003·JAMA : the Journal of the American Medical Association·Nir BarzilaiAlan R Shuldiner

❮ Previous
Next ❯

Citations

Feb 23, 2011·Cardiovascular Drugs and Therapy·John D HorowitzWillem J Remme
May 21, 2008·Current Atherosclerosis Reports·Robert S Rosenson
Mar 20, 2009·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Judith A Aberg
Oct 16, 2013·Perspectives in Public Health·Trevor WitterLee Stoner
Nov 4, 2006·Diabetes & Vascular Disease Research : Official Journal of the International Society of Diabetes and Vascular Disease·Terje R PedersenUNKNOWN European Expert Panel
Jun 18, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Syed Amir AshrafSibte Hadi
Feb 1, 2019·Regional Anesthesia and Pain Medicine·Tak Kyu OhJung-Won Hwang
Sep 27, 2020·Acta Anaesthesiologica Scandinavica·Tak Kyu Oh, In-Ae Song
Jun 3, 2020·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·Tak Kyu Oh, In-Ae Song

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.